QUEBEC CITY, June 6 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. today announced that Gilles Gagnon, President and Chief Executive Officer of the Company, will present a corporate update at the Pacific Growth Equities - Life Sciences Growth Conference Tuesday, June 13 2006 at 4:30 p.m. (Pacific Time) at the InterContinental Mark Hopkins Hotel in San Francisco. A live webcast of this presentation will be available on AEterna Zentaris’ website in the Investors section at www.aeternazentaris.com.
Mr. Gagnon will also present a Company update at the Orion Securities’ 11th Annual Healthcare Conference on Thursday, June 22 2006 at 11:30 a.m. (Eastern Time) at the Hotel Club Tremblant in Mont Tremblant, Quebec.
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is a growing global biopharmaceutical company engaged in the discovery, development and marketing of therapies for cancer and endocrine disorders.
AEterna Zentaris also owns 48.29% of the equity of Atrium Biotechnologies Inc. and 64.7% of its voting rights. Atrium is a developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutritional industries.
News releases and additional information are available at www.aeternazentaris.com.
AETERNA ZENTARIS INC. (FORMERLY/ANCIENNEMENT - LES LABORATOIRES AETERNA
CONTACT: Media Relations: Paul Burroughs, (418) 652-8525 ext. 406,paul.burroughs@aeternazentaris.com; Investor Relations: Jenene Thomas,(418) 655-6420 or (908) 996-3154, jenene.thomas@aeternazentaris.com; Torequest a free copy of this organization’s annual report, please go tohttp://www.newswire.ca and click on reports@cnw.
